Expand ARWR Menu
ARWR MENU

ARWR Stock Posts


$ARWR Earnings February 05 AMC. 20-Feb-26 Straddle Implies ±13.6% Move vs Prev. Move +23.3%
Upcoming Earnings

ARWR Arrowhead Pharmaceuticals68.10+0.04 (+0.1%)

Arrowhead Pharmaceuticals will report earnings after the market closes. View Calendar The market is expecting a ±12.8% move after earnings are reported. The average move for the past 4 quarters of earnings has been ±10.0%. View Expected Move (Conf Call: Feb 5 4:30 PM)
Unusual Option Volume

ARWR Arrowhead Pharmaceuticals65.80-0.45 (-0.7%)

Arrowhead Pharmaceuticals trades 1,320 contracts.
Unusual Option Volume

ARWR Arrowhead Pharmaceuticals64.54-0.46 (-0.7%)

Arrowhead Pharmaceuticals trades 6,416 contracts. The company has the following event: J.P. Morgan 2026 Healthcare Conference on Jan 12, 2026.
Unusual Option Volume

ARWR Arrowhead Pharmaceuticals67.89+2.20 (+3.4%)

Arrowhead Pharmaceuticals trades 1,184 contracts. The company has the following event: J.P. Morgan 2026 Healthcare Conference on Jan 12, 2026. News: Arrowhead Pharmaceuticals Prices Upsized Offerings of Convertible Senior Notes, Common Stock and Pre-Funded Warrants
Unusual Option Volume

ARWR Arrowhead Pharmaceuticals66.51-4.30 (-6.1%)

Arrowhead Pharmaceuticals trades 1,556 contracts. The company has the following event: J.P. Morgan 2026 Healthcare Conference on Jan 12, 2026. News: Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China
Market Data Delayed 15 Minutes